Jeffery Stolte

Jeffery Stolte is a seasoned venture capital professional currently serving as Senior Partner at Providence Ventures since 2014, where Jeffery successfully launched Providence Ventures Fund II, a $150 million fund dedicated to healthcare investments. Stolte leads all daily fund operations and investment activities, aiming to enhance strategic and investment value for Providence, one of the largest healthcare systems in the U.S. Previously, Stolte was the first venture capital executive hired by Providence, responsible for establishing the firm's inaugural venture capital fund. In addition to their role at Providence Ventures, Stolte holds several board and observer positions across various healthcare companies, including Kno2, SpineZone, Protenus, Trilliant Health, Intelligent Retinal Imaging Systems (IRIS), and Binary Fountain™. Stolte earned an MBA from The University of Chicago Booth School of Business and holds a Master of Science in Biomedical Informatics from Oregon Health & Science University, along with a Bachelor of Arts in BioPsychology from the University of Chicago.